These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 5027161)
21. [A new method of preparing and some properties of high molecular weight monoamine oxidase from swine liver mitochondria]. Nikol'skaia EB; Iagodina OV; Grinberg BA; Dianova MM Ukr Biokhim Zh (1978); 1998; 70(3):50-6. PubMed ID: 9848180 [TBL] [Abstract][Full Text] [Related]
22. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors]. Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140 [TBL] [Abstract][Full Text] [Related]
23. [Effect of various antidepressive agents on brain monoamine oxidase activity]. Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732 [TBL] [Abstract][Full Text] [Related]
24. Proceedings: Age dependent recovery of rat brain MAO activity after administration of a single dose of iproniazid and pargyline. Sprengeler T; Rakow D; Schulze G; Christ W Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R12. PubMed ID: 1143390 [No Abstract] [Full Text] [Related]
25. [In vivo and in vitro effect of N-morpholino-3-ethylamino-4 phenyl-6 pyridazine (Agr 620) on rat liver and brain mitochondrial monoamine oxidase]. Thuret F; Lamothe C; Laborit H Agressologie; 1970; 11(5):417-20. PubMed ID: 5516969 [No Abstract] [Full Text] [Related]
26. Monoamine oxidase (EC 1.4.3.4): isolation and characterization of multiple forms of the brain enzyme. Shih JC; Eiduson S J Neurochem; 1973 Jul; 21(1):41-9. PubMed ID: 4720902 [No Abstract] [Full Text] [Related]
27. [Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues]. Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD Vopr Med Khim; 1983; 29(5):118-23. PubMed ID: 6649522 [TBL] [Abstract][Full Text] [Related]
28. Iproniazid inhibition of monoamine oxidase: cytophotometric measurements in various regions of rabbit brain. Eadie MJ; Tyrer JH; Kukums JR Brain; 1968 Sep; 91(3):519-24. PubMed ID: 5723021 [No Abstract] [Full Text] [Related]
29. [Purification and modification of the catalytic properties of amine oxidases]. Akopian ZhI; Gvozdev RI; Molodykh GU; Stesina LN; Tat'ianenko LV Vopr Med Khim; 1972; 18(4):356-64. PubMed ID: 4196601 [No Abstract] [Full Text] [Related]
30. [Hydrazine derivative modification of the activity of brain mitochondrial monoamine oxidases]. Kalninia IE; Baumanas EA; Kaĭrane ChB; Gorkin VZ Vopr Med Khim; 1981; 27(6):773-9. PubMed ID: 7336653 [TBL] [Abstract][Full Text] [Related]
31. [On the selective inhibition by alpha-substituted tryptamine derivatives of the enzymatic deamination of serotonin]. Gorkin VZ; Tat'ianenko LV; Suvorov NN; Nekliudov AD Biokhimiia; 1967; 32(5):1036-46. PubMed ID: 5599890 [No Abstract] [Full Text] [Related]
32. Monoamine oxidase A and B from human liver and brain. Abell CW Methods Enzymol; 1987; 142():638-50. PubMed ID: 3600386 [No Abstract] [Full Text] [Related]
33. The flavin prosthetic group of purified rat liver mitochondrial monoamine oxidase. Youdim MB; Sourkes TL Adv Biochem Psychopharmacol; 1972; 5():45-53. PubMed ID: 5054213 [No Abstract] [Full Text] [Related]
34. Multiple forms of monoamine oxidase: functional significance. Sandler M; Youdim MB Pharmacol Rev; 1972 Jun; 24(2):331-48. PubMed ID: 4564605 [No Abstract] [Full Text] [Related]
37. [Kinetic properties of monoamine oxidase isoenzymes from the bovine brain]. Moskvitina TA; Kuchina NE; Gorkin VZ Vopr Med Khim; 1982; 28(5):127-31. PubMed ID: 7179829 [TBL] [Abstract][Full Text] [Related]
38. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid. Maître L J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494 [No Abstract] [Full Text] [Related]